SBFM board of directors
Dr. Steve Slilaty
Chairman & CEO
Dr. Slilaty is an accomplished scientist and a highly skilled business executive. He received his Bachelor of Science at Cornell University and completed his Ph.D. in Molecular Biology & Biochemistry at the University of Arizona. He is currently President & CEO of Sunshine Biopharma and has an appointment as Adjunct Professor at Universite du Quebec. Dr. Slilaty is a leader in the bioscience industry and is referenced in editorials, reviews and textbooks. His extensive contributions to science included the discovery of a new class of enzymes (S24) and the development of key technology for the Human Genome Project. With a passion for medicine, he founded three biotech companies and took one public. The company he took public, Genomics One Corporation reached $1 billion market cap. At Sunshine Biopharma Dr. Slilaty is working with the same determination as he pioneers a path towards the discovery of ground breaking drugs for the treatment of aggressive forms of cancer.
Camille Sebaaly, ENG.
Director & CFO
Mr. Sebaaly has more than 20 years of experience in high profile career spread heading the engineering, development, commercialization and market launch of emerging technologies worldwide.
Michael Di Turi
Director & COO
Mr. Di Turi has more than 10 years experience in management, banking, business development, marketing and sales.
News 
Market Data 
Discover 
AI
